Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong
· Delayed Price · Currency is HKD
44.00
+2.66 (6.43%)
At close: Dec 5, 2025
HKG:2591 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 132.34 | 86.85 | 255.74 |
| Research & Development | 149.69 | 102.51 | 492.11 |
| Other Operating Expenses | 3.11 | 0.06 | 0.06 |
| Operating Expenses | 285.14 | 189.42 | 747.91 |
| Operating Income | -234.65 | -189.42 | -747.91 |
| Interest Expense | -0.43 | -0.87 | -2.32 |
| Interest & Investment Income | 3.87 | 3.82 | 4.19 |
| Currency Exchange Gain (Loss) | 0.43 | 0.7 | 0.71 |
| Other Non Operating Income (Expenses) | 0.25 | 0.21 | 9.85 |
| EBT Excluding Unusual Items | -230.53 | -185.57 | -735.48 |
| Gain (Loss) on Sale of Investments | 8.65 | 11.17 | 2.1 |
| Gain (Loss) on Sale of Assets | - | -4.45 | - |
| Other Unusual Items | - | 4.15 | - |
| Pretax Income | -221.89 | -174.69 | -733.38 |
| Net Income | -221.89 | -174.69 | -733.38 |
| Net Income to Common | -221.89 | -174.69 | -733.38 |
| Shares Outstanding (Basic) | 420 | 420 | 383 |
| Shares Outstanding (Diluted) | 420 | 420 | 383 |
| Shares Change (YoY) | - | 9.63% | - |
| EPS (Basic) | -0.53 | -0.42 | -1.92 |
| EPS (Diluted) | -0.53 | -0.42 | -1.92 |
| Free Cash Flow | -174.46 | -166.57 | -176.64 |
| Free Cash Flow Per Share | -0.41 | -0.40 | -0.46 |
| EBITDA | -223.94 | -174.91 | -733.76 |
| D&A For EBITDA | 10.71 | 14.51 | 14.14 |
| EBIT | -234.65 | -189.42 | -747.91 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.